(Q36911495)

17 August 2017

1 reference

title

Hematopoietic stem cell transplantation in peripheral T-cell lymphomas (English)

1 reference

ORCID Public Data File 2021

17 August 2017

1 reference

author name string

Corradini Paolo

series ordinal

1

1 reference

17 August 2017

Farina Lucia

series ordinal

2

1 reference

17 August 2017

Dodero Anna

series ordinal

3

1 reference

17 August 2017

publication date

1 August 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

48

1 reference

17 August 2017

issue

8

1 reference

17 August 2017

page(s)

1496-1501

1 reference

Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190701435275

10.1080/10428190701435275

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference